Skip to main content

Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents

Publication ,  Conference
Ross, JS; Wang, K; Gay, LM; Al-Rohil, RN; Nazeer, T; Sheehan, CE; Jennings, TA; Otto, GA; Donahue, A; He, J; Palmer, G; Ali, S; Nahas, M ...
Published in: LABORATORY INVESTIGATION
February 1, 2014

Duke Scholars

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

February 1, 2014

Volume

94

Start / End Page

256A / 256A

Location

San Diego, CA

Publisher

NATURE PUBLISHING GROUP

Conference Name

103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ross, J. S., Wang, K., Gay, L. M., Al-Rohil, R. N., Nazeer, T., Sheehan, C. E., … Stephens, P. J. (2014). Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. In LABORATORY INVESTIGATION (Vol. 94, pp. 256A-256A). San Diego, CA: NATURE PUBLISHING GROUP.
Ross, J. S., K. Wang, L. M. Gay, R. N. Al-Rohil, T. Nazeer, C. E. Sheehan, T. A. Jennings, et al. “Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents.” In LABORATORY INVESTIGATION, 94:256A-256A. NATURE PUBLISHING GROUP, 2014.
Ross JS, Wang K, Gay LM, Al-Rohil RN, Nazeer T, Sheehan CE, Jennings TA, Otto GA, Donahue A, He J, Palmer G, Ali S, Nahas M, Young G, LaBrecque E, Frampton G, Erlich R, Curran JA, Brennan K, Downing SR, Yelensky R, Lipson D, Hawryluk M, Miller VA, Stephens PJ. Next-Generation Sequencing (NGS) Reveals a High Frequency of IHC/FISH Negative Activating Extracellular Domain ERBB2 (HER2) Mutations in Micropapillary Urothelial Carcinoma That Can Respond to Anti-HER2 Targeting Agents. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 256A-256A.

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

February 1, 2014

Volume

94

Start / End Page

256A / 256A

Location

San Diego, CA

Publisher

NATURE PUBLISHING GROUP

Conference Name

103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences